Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CNTN
STRONG SELLCanton Strategic Holdings, Inc. · Healthcare · United States · $150M · Avg Vol: $2M/d
COMPANY DESCRIPTION
Canton Strategic Holdings is a holding company actively seeking to acquire and develop businesses, with a stated focus on opportunities within the healthcare sector. Operating as an investment vehicle, it aims to build a diversified portfolio through strategic mergers and acquisitions. The company's future growth is dependent on its ability to successfully identify and integrate target businesses.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 0 | — | — |
| EPS | — | -0.11 | -1.09 | -0.24 | -0.54 | — | -0.36 |
| Shares | — | 77.1M | 77.1M | 77.1M | 77.1M | 0.0% | 77.1M |
| Debt | 2.2M | — | — | — | — | — | — |
| Equity | — | 5.5M | 9.1M | 1.3M | 397.9M | 315.6% | — |
| Op CF | — | -6.6M | -7.3M | -10.9M | -16.1M | — | -21.1M |
| Inv CF | — | 0 | 0 | 0 | -77.6M | — | — |
| Fin CF | — | 13.1M | 11.7M | 3.5M | 107.2M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CNTN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CNTN | Canton Strategic Holdings, Inc.(you) | $150M | 15 | STRONG SELL |
| ABOS | Acumen Pharmaceuticals, Inc. | $154M | 15 | STRONG SELL |
| UNCY | Unicycive Therapeutics, Inc. | $148M | 14 | STRONG SELL |
| ARCT | Arcturus Therapeutics Holdings Inc. | $157M | 15 | STRONG SELL |
| CDXS | Codexis, Inc. | $135M | 14 | STRONG SELL |
| PYXS | Pyxis Oncology, Inc. | $165M | 14 | STRONG SELL |
| TNYA | Tenaya Therapeutics, Inc. | $168M | 15 | STRONG SELL |
| KRRO | Korro Bio, Inc. | $153M | 12 | STRONG SELL |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $170M | 15 | STRONG SELL |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $157M | 12 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%